Tocilizumab for Systemic Juvenile Idiopathic Arthritis Reply

被引：12
|
作者：
De Benedetti, Fabrizio [1 ]
机构：
[1] Osped Pediat Bambino Gesu, Rome, Italy
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 368卷 / 13期
关键词：
MACROPHAGE ACTIVATION SYNDROME; INTERLEUKIN-6;
D O I：
10.1056/NEJMc1301017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1256 / 1257
页数：2
相关论文
共 50 条
  • [1] Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
    Herlin, Troels
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (06) : 517 - 525
  • [2] Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
    Murakami, Miho
    Tomiita, Minako
    Nishimoto, Norihiro
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2012, 4 : 71 - 79
  • [3] Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
    De Benedetti, Fabrizio
    Brunner, Hermine I.
    Ruperto, Nicolino
    Kenwright, Andrew
    Wright, Stephen
    Calvo, Inmaculada
    Cuttica, Ruben
    Ravelli, Angelo
    Schneider, Rayfel
    Woo, Patricia
    Wouters, Carine
    Xavier, Ricardo
    Zemel, Lawrence
    Baildam, Eileen
    Burgos-Vargas, Ruben
    Dolezalova, Pavla
    Garay, Stella M.
    Merino, Rosa
    Joos, Rik
    Grom, Alexei
    Wulffraat, Nico
    Zuber, Zbigniew
    Zulian, Francesco
    Lovell, Daniel
    Martini, Alberto
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2385 - 2395
  • [4] Rapid desensitisation to tocilizumab in systemic idiopathic juvenile arthritis
    Villarreal Gonzalez, Rosalaura
    Gonzalez Diaz, Sandra
    de Lira Quezada, Cindy
    Macias Weinmann, Alejandra
    Acuna Ortega, Nathalhie
    ANALES DE PEDIATRIA, 2021, 94 (03): : 180 - 181
  • [5] Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis
    Zhang, Xiaoping
    Morcos, Peter N.
    Saito, Tomohisa
    Terao, Kimio
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (02) : 123 - 137
  • [6] Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
    Horneff G.
    Huppertz I.
    Haas P.
    Minden K.
    Ganser G.
    Hospach A.
    Trauzeddel R.
    Pediatric Rheumatology, 13 (Suppl 1)
  • [7] Tocilizumab: molecular intervention therapy in children with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Kishimoto, Tadamitsu
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2010, 6 (05) : 735 - 743
  • [8] Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis
    Gupta, Ayush
    Bagri, Narendra Kumar
    Tripathy, Saroj Kumar
    Barwad, Adarsh
    Phulware, Ravi Hari
    Hari, Pankaj
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (01) : 153 - 159
  • [9] Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis
    Ayush Gupta
    Narendra Kumar Bagri
    Saroj Kumar Tripathy
    Adarsh Barwad
    Ravi Hari Phulware
    Pankaj Hari
    Rheumatology International, 2020, 40 : 153 - 159
  • [10] SUCCESSFUL RAPID TOCILIZUMAB DESENSITIZATION IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
    Villarreal Gonzalez, R.
    Gonzalez-Diaz, S.
    Arias-Cruz, A.
    Macias-Weinmann, A.
    De Lira-Quezada, C.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S70 - S70
12345